Manufacturer of Controlled Substances; Notice of Application; Cerilliant Corporation, 47108-47109 [2012-19199]

Agencies

• Drug Enforcement Administration
• Department of Justice

[Federal Register Volume 77, Number 152 (Tuesday, August 7, 2012)]
[Notices]
[Pages 47108-47109]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-19199]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Cerilliant Corporation

    Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this 
is notice that on July 6, 2012, Cerilliant Corporation, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78665-2402, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as an importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methcathinone (1237).............................  I
4-Methyl-N-methylcathinone (1248)................  I
N-Ethylamphetamine (1475)........................  I
N,N-Dimethylamphetamine (1480)...................  I
Fenethylline (1503)..............................  I
Gamma Hydroxybutyric Acid (2010).................  I
JWH-018 (7118)...................................  I
JWH-073 (7173)...................................  I
JWH-200 (7200)...................................  I
Alpha-ethyltryptamine (7249).....................  I
Ibogaine (7260)..................................  I
CP-47497 (7297)..................................  I
CP-47497 C8 Homologue (7298).....................  I
Lysergic acid diethylamide (7315)................  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine       I
 (7348).
Marihuana (7360).................................  I
Tetrahydrocannabinols (7370).....................  I
Mescaline (7381).................................  I
3,4,5-Trimethoxyamphetamine (7390)...............  I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).......  I
4-Methyl-2,5-dimethoxyamphetamine (7395).........  I
2,5-Dimethoxyamphetamine (7396)..................  I
3,4-Methylenedioxyamphetamine (7400).............  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (7405).........  I
4-Methoxyamphetamine (7411)......................  I
5-Methoxy-N-N-dimethyltryptamine (7431)..........  I
Alpha-methyltryptamine (7432)....................  I
Diethyltryptamine (7434).........................  I
Dimethyltryptamine (7435)........................  I
Psilocybin (7437)................................  I
Psilocyn (7438)..................................  I

[[Page 47109]]

 
5-Methoxy-N,N-diisopropyltryptamine (7439).......  I
N-Benzylpiperazine (7493)........................  I
3,4-Methylenedioxypyrovalerone (7535)............  I
3,4-Methylenedioxy-N-methylcathinone (7540)......  I
Desomorphine (9055)..............................  I
Etorphine (except HCl)(9056).....................  I
Heroin (9200)....................................  I
Morphine-N-oxide (9307)..........................  I
Normorphine (9313)...............................  I
Pholcodine (9314)................................  I
Dextromoramide (9613)............................  I
Dipipanone (9622)................................  I
Racemoramide (9645)..............................  I
Trimeperidine (9646).............................  I
1-Methyl-4-phenyl-4-propionoxypiperidine (9661)..  I
Tilidine (9750)..................................  I
Amphetamine (1100)...............................  II
Methamphetamine (1105)...........................  II
Methylphenidate (1724)...........................  II
Amobarbital (2125)...............................  II
Pentobarbital (2270).............................  II
Secobarbital (2315)..............................  II
Phencyclidine (7471).............................  II
Phenylacetone (8501).............................  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Dihydrocodeine (9120)............................  II
Oxycodone (9143).................................  II
Hydromorphone (9150).............................  II
Benzoylecgonine (9180)...........................  II
Ethylmorphine (9190).............................  II
Meperidine (9230)................................  II
Methadone (9250).................................  II
Dextropropoxyphene, bulk (non-dosage forms)        II
 (9273).
Morphine (9300)..................................  II
Oripavine (9330).................................  II
Thebaine (9333)..................................  II
Levo-alphacetylmethadol (9648)...................  II
Oxymorphone (9652)...............................  II
Poppy Straw Concentrate (9670)...................  II
Alfentanil (9737)................................  II
Sufentanil (9740)................................  II
Fentanyl (9801)..................................  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the manufacture of analytical reference 
standards.
    In reference to drug codes 7360 and 7370, the company plans to 
import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No 
other activity for this drug code is authorized for this registration.
    Comments and requests for hearing on applications to import 
narcotic raw material are not appropriate. 72 FR 3417(2007).
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances listed in schedules I or II, which fall under the authority 
of section 1002(a)(2)(B) of the Act 21 U.S.C. 952 (a)(2)(B) may, in the 
circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR Sec.  1301.43 and in such form as prescribed by 21 
CFR Sec.  1316.47.
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than September 6, 2012.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR Sec.  1301.34(b), 
(c), (d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants 
for registration to import a basic class of any controlled substances 
in schedules I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 
21 CFR Sec.  1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: July 30, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-19199 Filed 8-6-12; 8:45 am]
BILLING CODE 4410-09-P